Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ABL1 | P00519 | 1/20 | 0.52 |
| ▸ | RET | P07949 | 1/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.52 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.52 |
| ▸ | FLT3 | P36888 | 1/20 | 0.52 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7008915 | 0.88 | ALDH1A1 (0.73) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL1077379 | 0.86 | ALDH1A1 (0.62) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25299252 | 0.85 | ALDH1A1 (0.60) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25256791 | 0.85 | ALDH1A1 (0.60) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25294630 | 0.85 | ALDH1A1 (0.60) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25258780 | 0.84 | SMN1; SMN2 (0.60) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL15132785 | 0.83 | HPGD (0.57) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25258308 | 0.83 | ALDH1A1 (0.48) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25258164 | 0.83 | SMN1; SMN2 (0.58) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 | |
| SCHEMBL25294601 | 0.83 | SMN1; SMN2 (0.58) | ALDH1A1KMT2APOLBHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118110-A | Preparation of bromine-containing seven-membered boron fluoride compound and application of bromine-containing seven-membered boron fluoride compound in fluorescent ink | 三峡大学 | 2025-06-10 | — | — | CN | claimed |
| CN-117362615-A | Modified alkyd resin and varnish composition containing modified alkyd resin | 西北永新涂料有限公司 | 2024-01-09 | — | — | CN | claimed |
| US-20260049217-A1 | DYED ARTICLES FOR VISIBLE LIGHT FILTERING | OAKLEY, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260049192-A1 | DYED ARTICLES FOR VISIBLE AND INFRARED LIGHT ABSORPTION | OAKLEY, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260043944-A1 | OPTICAL FILM, DISPLAY DEVICE, AND ULTRAVIOLET ABSORBING LAYER FORMING COMPOSITION | TOPPAN HOLDINGS INC. (JP) | 2026-02-12 | — | — | US | disclosed |
| WO-2025233641-A1 | NOVEL PHOTOINDUCIBLE KINASE INHIBITORS FOR TREATING PROLIFERATIVE AND VASOPROLIFERATIVE DISEASES | SEMMELWEIS EGYETEM (HU) | 2025-11-13 | — | — | WO | disclosed |
| CN-120271615-A | BF-containing2Preparation method of seven-membered boron fluoride compound and application of seven-membered boron fluoride compound in fluorescent anti-counterfeiting film | 三峡大学 | 2025-07-08 | — | — | CN | disclosed |
| CN-120118110-A | Preparation of bromine-containing seven-membered boron fluoride compound and application of bromine-containing seven-membered boron fluoride compound in fluorescent ink | 三峡大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-120118110-A | Preparation of bromine-containing seven-membered boron fluoride compound and application of bromine-containing seven-membered boron fluoride compound in fluorescent ink | 三峡大学 | 2025-06-10 | — | — | CN | disclosed |
| US-20250172723-A1 | OPTICAL FILM AND DISPLAY DEVICE | TOPPAN HOLDINGS INC. (JP) | 2025-05-29 | — | — | US | disclosed |
| US-20250089549-A1 | OPTICAL FILM, COMPOSITION FOR FORMING COLORED LAYER, DIPYRROMETHENE COBALT COMPLEX AND DISPLAY DEVICE | TOPPAN HOLDINGS INC. (JP) | 2025-03-13 | — | — | US | disclosed |
| EP-0934931-A2 | 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators | Sugen, Inc. (US) | 1999-08-11 | — | — | EP | disclosed |
| US-5886020-A | MODULATING TYROSINE KINASE SIGNAL TRANSDUCTION IN ORDER TO REGULATE OR INHIBIT ABNORMAL CELL PROLIFERATION | SUGEN, INC. (US) | 1999-03-23 | — | — | US | disclosed |
| US-5883113-A | TYROSINE KINASE INHIBITORS; ANTIPROLIFERATIVE AND ANTICARCINOGENIC AGENTS; DIABETES, ARTHRITIS, RESTENOSIS, ATHEROSCLEROSIS | SUGEN, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5883116-A | ANTITUMOR AGENTS AND ENZYME INHIBITORS | SUGEN, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5834504-A | MODULATING, INHIBITING ABNORMAL CELL PROLIFERATION; ENZYME INHIBITION | SUGEN, INC. (US) | 1998-11-10 | — | — | US | disclosed |
| EP-0769947-A4 | INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE | SUGEN INC (US) | 1998-09-30 | — | — | EP | disclosed |
| US-5792783-A | CAPABLE OF MODULATING TYROSINE KINASE SIGNAL TRANSDUCTION IN ORDER TO REGULATE, MODULATE AND/OR INHIBIT ABNORMAL CELL PROLIFERATION | SUGEN, INC. (US) | 1998-08-11 | — | — | US | disclosed |
| EP-0769947-A1 | INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE | Sugen, Inc. (US) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996040116-A1 | INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE | SUGEN, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043944-A1 | OPTICAL FILM, DISPLAY DEVICE, AND ULTRAVIOLET ABSORBING LAYER FORMING COMPOSITION | KDM5A, VCL, KDM5B | ALDH1A1 211/4885KMT2A 286/4885POLB 3032/4885 |
| US-20260049217-A1 | DYED ARTICLES FOR VISIBLE LIGHT FILTERING | LBR, CRY2, CORO1C | ALDH1A1 845/4885KMT2A 3902/4885POLB 3574/4885 |
| US-20260049192-A1 | DYED ARTICLES FOR VISIBLE AND INFRARED LIGHT ABSORPTION | CRY1, CRY2, CLIC1 | ALDH1A1 319/4885KMT2A 3787/4885POLB 2713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.